LI
APLT

Leap Investments’s Applied Therapeutics APLT Stock Holding History

Leap Investments’s Portfolio APLT Stock Details APLT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-12,858
Closed -$351K – 359
2019
Q4 		$351K Buy
+12,858
New +$220K 0.16% 210

Other funds holding APLT

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Leap Investments's APLT Position: Q1 2020 in Review

Leap Investments sold out of Applied Therapeutics (APLT) in Q1 2020, closing a stake of 12,858 shares — an estimated $351K sold.

Leap Investments first reported a position in APLT in Q4 2019 and held it in 1 quarter. The position peaked at $351K in Q4 2019. 64 funds tracked by Wall St. Rank hold APLT as of Q1 2020.

  • Leap Investments reported no remaining Applied Therapeutics position as of Q1 2020 after selling out during the quarter.
  • Leap Investments sold 12,858 Applied Therapeutics shares in Q1 2020, an estimated $351K.
  • Leap Investments first reported a position in Applied Therapeutics in Q4 2019 and held it in 1 quarter.
  • Leap Investments's Applied Therapeutics position peaked at $351K in Q4 2019.
  • 64 funds tracked by Wall St. Rank held Applied Therapeutics as of Q1 2020.

Based on Leap Investments's 13F filing for Q1 2020, filed 15 May 2020.